1Siegel I, Liu TL,Gieicher N. The red-cell immune system[J]. Lancet,1981,2(8246) :556.
2Herndler-Brandstetter D,Schwaiger S, Veel E,et al. CD25-expressing CD8+ T cells are potent memory cells in old age[J]. J Immunol, 2005,175 (3) :1566-1574.
3Forslid J ,Hed J ,Stendahl O. Erythrocyte enhancement of C3b-mediated phagocytosis in human neutrophils in vitro:A combined effect of the erythrocyte complement receptor CR1 and erythrocyte scavengers to reactive oxygen metabolites[J]. Immunology, 1985, 55(1):97.
4Kawashima H,Inage Y,Ogihara M. Serum and cerebrospinal fluid nitrite/nitrate levels in patients with rotavirus gastroenteritis induced convulsion[J]. Life Sci, 2004,74 : 1397-1405.
6John B,Crispe IN. TLR-4 regulates CD8+ T cell trapping in the liver [J]. J immunol, 2005,175 (3): 1643-1650.
7Paccaud JP,Carpentier JL,Schifferli JA. Difference in the clustering of complement receptor type 1 (CR1)on polymorphonuclear leukocytes and erythrocytes effect on immune adherence[J]. Eur J Immunol,1990,20(2) :283.
8Uotta LA, Petricoin EF. Serum pepfidome for cancer detection: spinning biologic trash into diagnostic gold[J]. J Clin Invest, 2006,116:26-30.
9Liotta LA, Ferrari M, Petricoin E. Clinical proteomics : written in blood[J]. Nature, 2003,425 : 905.
10Shau H,Gupta RK,Golub SH. Identification of natural killer enhancing factor (NKEF) from human erythroid cell [J]. Cell Immunol, 1993,147 (1) : 1.
二级参考文献27
1Hanash S. HUPO initiatives relevant to clinical proteomics. Mol Cell Proteomics, 2004, 3 (4): 298-301.
2Johann D J, Jr., McGuigan M D, Patel A R, et cd. Clinical proteomics and biomarker discovery. Ann N Y Acad Sci, 2004, 1022:295-305.
3Wultkuhle J D, Liotta L A, Petricoin E F. Proteomic applications for the early detection of cancer. Nat Rev Cancer, 2003, 3 (4): 267-275.
4Rai A J, Zhang Z, Rosenzweig J, et ol. Proteomic approaches to tumor marker discovery. Arch Pathol Lab Med, 2002, 126(12):1518-1526.
5Zhang Z, Bast R C, Jr., Yu Y, et ol. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res, 2004, 64 (16): 5882-5890.
6Colantonio D A, Chan D W. The clinical application of proteomics.Clin Chim Acta, 2005, 357 (2): 151 - 158.
7Rai A J, Gelfand C A, Haywood B C, et cd. HUPO Plasma Proteome Project specimen collection and handling: Towards the standardization of parameters for plasma proteome samples.Proteomics, 2005, 5(13): 3262-3277.
8White C N, Chan D W, Zhang Z. Bioinformatics strategies forproteomic profiling. Clin Biochem, 2004, 37 (7): 636-641.
9Emmert-Buck M R, Bonner R F, Smith P D, et al. Laser capture microdissection. Science, 1996, 274 (5289): 998 - 1001.
10Liotta L A, Ferrari M, Petdcoin E. Clinical proteomics: written in blood. Nature, 2003, 425 (6961): 905.
